4.2 Review

Lactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems

Journal

PROTEIN EXPRESSION AND PURIFICATION
Volume 79, Issue 2, Pages 165-175

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.pep.2011.06.005

Keywords

Lactic acid bacteria; Lactococcus lactis; Heterologous expression; Delivery systems; Vaccines

Funding

  1. CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)
  2. COFECUB (Comite Francais d'Etudes et de Cooperation Universitaire avec le Bresil)
  3. CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [CAPES-COFECUB 2010 720/11, CNPq PQ2 309135/2010-9]
  4. CROSS TALK program

Ask authors/readers for more resources

Lactic acid bacteria (LAB), widely used in the food industry, are present in the intestine of most animals, including humans. The potential use of these bacteria as mucosal delivery vehicles for vaccinal, medical or technological use has been extensively investigated. Lactococcus Iactis, a LAB species, is a potential candidate for the production of biologically useful proteins and for plasmid DNA delivery to eukaryotic cells. Several delivery systems have been developed to target heterologous proteins to a specific cell location (i.e., cytoplasm, cell wall or extracellular medium) and more recently to efficiently transfer DNA to eukaryotic cells. A promising application of L lactis is its use for the development of live mucosal vaccines. Here, we have reviewed the expression of heterologous protein and the various delivery systems developed for L. lactis, as well as its use as an oral vaccine carrier. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available